Search

Search Results

1. Dystrophin genetic variants and autism

   Loss-of-function variants in the dystrophin gene, a well-known cause of muscular dystrophies, have emerged as a mutational risk mechanism for autism...

   Maria Rita Passos-Bueno, Claudia Ismania Samogy Costa, Mayana Zatz in Discover Mental Health

   Article Open access 24 March 2022
   

2. Does lumbar lordosis minus thoracic kyphosis predict the clinical outcome of patients with adult degenerative scoliosis?

   Purpose

   To evaluate the predictive effect of lumbar lordosis minus thoracic kyphosis (LL-TK) in the surgical outcome of adult degenerative scoliosis...

   Siyu Zhou, Wei Li, ... Weishi Li in Journal of Orthopaedic Surgery and Research

   Article Open access 03 September 2019
   

3. Phenytoin, Valproat, Levetiracetam und Lacosamid im Status epilepticus

   Benzodiazepine refractory or established status epilepticus (ESE) is defined as ongoing seizure activity despite the use of benzodiazepines. In...

   Francesco Brigo, Gudrun Kalss, Eugen Trinka in Zeitschrift für Epileptologie

   Article Open access 01 October 2018

4. Current radiotracers to image neurodegenerative diseases

   The term of neurodegenerative diseases covers a heterogeneous group of disorders that are distinguished by progressive degeneration of the structure...

   Solveig Tiepolt, Marianne Patt, ... Osama Sabri in EJNMMI Radiopharmacy and Chemistry

   Article Open access 26 July 2019
   

5. Improving Outcomes in Infantile Spasms: Role of Pharmacotherapy

   Infantile spasms, and specifically within the context of West syndrome , is one of the most common epileptic encephalopathies to occur in early...

   Anand Iyer, Richard Appleton in Pediatric Drugs

   Article 19 August 2016

6. Pharmacotherapy for Dravet Syndrome

   Dravet syndrome (DS) is an intractable pediatric epilepsy syndrome, starting in early childhood. This disorder typically manifests with febrile...

   Adam Wallace, Elaine Wirrell, Daniel L. Kenney-Jung in Pediatric Drugs

   Article 10 March 2016
   

7. International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe

   In Europe, the number of antiepileptic drugs (AEDs) licensed for dogs has grown considerably over the last years. Nevertheless, the same questions...

   Sofie F.M. Bhatti, Luisa De Risio, ... Holger A. Volk in BMC Veterinary Research

   Article Open access 28 August 2015
   

8. Global quantitative analysis of phosphorylation underlying phencyclidine signaling and sensorimotor gating in the prefrontal cortex

   Prepulse inhibition (PPI) is an example of sensorimotor gating and deficits in PPI have been demonstrated in schizophrenia patients. Phencyclidine...

   D B McClatchy, J N Savas, ... J R Yates III in Molecular Psychiatry

   Article 14 April 2015
   

9. Synaptisches Vesikelprotein 2A

   Both levetiracetam (LEV) and brivaracetam (BRV) specifically bind to the synaptic vesicle protein 2A (SV2A). Synaptic vesicle protein 2A is part of...

   R. Surges, S. Schoch, C.E. Elger in Zeitschrift für Epileptologie

   Article 13 June 2012
   

10. Use of the newer antiepileptic drugs in pediatric epilepsies

    Children with epilepsy, particularly infants, differ from adults not only in the clinical manifestations of their seizures but also in the presence...

    Amy D. Malphrus, Angus A. Wilfong in Current Treatment Options in Neurology

    Article 01 July 2007

11. Azimilide for Atrial Fibrillation: Clinical Trial Results and Implications

    Azimilide dihydrochloride (or azimilide) is a class III antiarrhythmic drug currently under investigation that has been tested in atrial fibrillation...

    Edward L.C. Pritchett, Stephen R. Marcello in Cardiac Electrophysiology Review

    Article 01 September 2003